Sintx Technologies (SINT) Stock Analysis
NASDAQHealthcareMedical - Devices
What Sintx Technologies does
Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States. Its diverse portfolio includes solid and porous silicon nitride, silicon nitride powder, and specialized coating products, along with advanced silicon nitride composite materials and polyetherketoneketone. Established in 1996, this company, once known as Amedica Corporation, has its corporate headquarters situated in Salt Lake City, Utah.
Key metrics
ETFs linked to SINT
Broad-market and Healthcare sector ETFs an investor holding Sintx Technologies is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how SINT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze SINT in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Sintx Technologies?
- Sintx Technologies trades under the ticker SINT on NASDAQ.
- Which exchange is SINT listed on?
- SINT is listed on NASDAQ.
- What sector does Sintx Technologies operate in?
- Sintx Technologies is classified in the Healthcare sector (Medical - Devices industry).
- How can PortView help analyze SINT in a portfolio?
- PortView shows SINT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.